
LINK . SPRINGER . COM {
}
Title:
Safety and efficacy of sorafenib in Japanese patients with hepatocellular carcinoma in clinical practice: a subgroup analysis of GIDEON | Journal of Gastroenterology
Description:
GIDEON was a prospective, global, non-interventional study evaluating the safety of sorafenib in patients with unresectable hepatocellular carcinoma in real-world practice. The aim of this subgroup analysis was to assess the safety and efficacy of sorafenib as used by Japanese patients. In Japan, 508 patients were valid for safety analysis. Efficacy and safety were evaluated by the Child-Pugh score. The number of patients with Child-Pugh A and B was 432 (85.0 %) and 58 (11.4 %), respectively. The median overall survival time and time to progression in patients with Child-Pugh A and Child-Pugh B were 17.4 and 4.9 months, 3.7 and 2.3 months, respectively. The most common drug-related adverse events (AEs) included hand-foot skin reaction (47.8 %), diarrhea (35.8 %) and hypertension (24.2 %). The incidences of all or drug-related AEs were similar between patients with Child-Pugh A and B. However, all or drug-related serious AEs, AEs resulting in permanent discontinuation of sorafenib and deaths were observed more frequently in patients with Child-Pugh B compared with Child-Pugh A. Duration of treatment tended to be shorter as the Child-Pugh score worsened. Sorafenib was well tolerated by Japanese HCC patients in clinical settings. Patients with Child-Pugh B had shorter duration of treatment and higher incidence of SAEs. It is important to carefully evaluate patients’ conditions and assess the benefit and risk before making a decision to treat patients with sorafenib.
Website Age:
28 years and 1 months (reg. 1997-05-29).
Matching Content Categories {📚}
- Education
- Insurance
- Science
Content Management System {📝}
What CMS is link.springer.com built with?
Custom-built
No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.
Traffic Estimate {📈}
What is the average monthly size of link.springer.com audience?
🌠 Phenomenal Traffic: 5M - 10M visitors per month
Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Link.springer.com Make Money? {💸}
We see no obvious way the site makes money.
Not all websites are made for profit; some exist to inform or educate users. Or any other reason why people make websites. And this might be the case. Link.springer.com might be cashing in, but we can't detect the method they're using.
Keywords {🔍}
patients, sorafenib, childpugh, article, hepatocellular, carcinoma, japan, treatment, pubmed, aes, google, scholar, study, bclc, liver, stage, japanese, drugrelated, safety, incidence, analysis, gideon, cancer, therapy, hcc, ttp, tace, higher, score, median, cas, table, data, kudo, surveillance, received, efficacy, regions, shown, months, rate, pharma, pharmaceutical, number, time, similar, practice, global, start, sessions,
Topics {✒️}
hand-foot skin reaction article download pdf raf/mek/erk pathway post-marketing surveillance manager gideon original article—liver hepatocellular carcinoma–current status intermediate-stage hepatocellular carcinoma treatment-emergent death occurring worse child-pugh score transarterial chemoembolization failure/refractoriness drug-related aes reported child-pugh score worsened open-label study real-world practice data advanced hepatocellular carcinoma oral multikinase inhibitor baseline child-pugh status privacy choices/manage cookies satoshi yamashita related subjects full access drug-related aes author information authors daily medical practice complex medical situation cancer-related death real-world practice masatoshi kudo hepatic-related events transcatheter arterial chemoembolization drug-related saes article kudo abnormal laboratory tests nat rev cancer metastatic colorectal cancer molecular mechanisms involved conditions privacy policy phase iii randomised unresectable hepatocellular carcinoma outpatients diagnosed histologically decreased platelet count advisory committee immediately aliment pharmacol ther ethics declarations conflict kyowa hakko kirin bristol-myers squibb response evaluation criteria decrease patient quality advanced bclc stage limit daily activities
Schema {🗺️}
WebPage:
mainEntity:
headline:Safety and efficacy of sorafenib in Japanese patients with hepatocellular carcinoma in clinical practice: a subgroup analysis of GIDEON
description:GIDEON was a prospective, global, non-interventional study evaluating the safety of sorafenib in patients with unresectable hepatocellular carcinoma in real-world practice. The aim of this subgroup analysis was to assess the safety and efficacy of sorafenib as used by Japanese patients. In Japan, 508 patients were valid for safety analysis. Efficacy and safety were evaluated by the Child-Pugh score. The number of patients with Child-Pugh A and B was 432 (85.0 %) and 58 (11.4 %), respectively. The median overall survival time and time to progression in patients with Child-Pugh A and Child-Pugh B were 17.4 and 4.9 months, 3.7 and 2.3 months, respectively. The most common drug-related adverse events (AEs) included hand-foot skin reaction (47.8 %), diarrhea (35.8 %) and hypertension (24.2 %). The incidences of all or drug-related AEs were similar between patients with Child-Pugh A and B. However, all or drug-related serious AEs, AEs resulting in permanent discontinuation of sorafenib and deaths were observed more frequently in patients with Child-Pugh B compared with Child-Pugh A. Duration of treatment tended to be shorter as the Child-Pugh score worsened. Sorafenib was well tolerated by Japanese HCC patients in clinical settings. Patients with Child-Pugh B had shorter duration of treatment and higher incidence of SAEs. It is important to carefully evaluate patients’ conditions and assess the benefit and risk before making a decision to treat patients with sorafenib.
datePublished:2016-04-22T00:00:00Z
dateModified:2016-04-22T00:00:00Z
pageStart:1150
pageEnd:1160
license:http://creativecommons.org/licenses/by/4.0/
sameAs:https://doi.org/10.1007/s00535-016-1204-2
keywords:
Hepatocellular carcinoma
Sorafenib
Japanese
GIDEON
Gastroenterology
Hepatology
Abdominal Surgery
Colorectal Surgery
Surgical Oncology
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00535-016-1204-2/MediaObjects/535_2016_1204_Fig1_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00535-016-1204-2/MediaObjects/535_2016_1204_Fig2_HTML.gif
isPartOf:
name:Journal of Gastroenterology
issn:
1435-5922
0944-1174
volumeNumber:51
type:
Periodical
PublicationVolume
publisher:
name:Springer Japan
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Masatoshi Kudo
affiliation:
name:Kinki University School of Medicine
address:
name:Department of Gastroenterology and Hepatology, Kinki University School of Medicine, Osaka-Sayama, Japan
type:PostalAddress
type:Organization
email:[email protected]
type:Person
name:Masafumi Ikeda
affiliation:
name:National Cancer Center Hospital East
address:
name:Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, Chiba, Japan
type:PostalAddress
type:Organization
type:Person
name:Tadatoshi Takayama
affiliation:
name:Nihon University School of Medicine
address:
name:Department of Digestive Surgery, Nihon University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
type:Person
name:Kazushi Numata
affiliation:
name:Yokohama City University Medical Center
address:
name:Gastroenterological Center, Yokohama City University Medical Center, Kanagawa, Japan
type:PostalAddress
type:Organization
type:Person
name:Namiki Izumi
affiliation:
name:Musashino Red Cross Hospital
address:
name:Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Tokyo, Japan
type:PostalAddress
type:Organization
type:Person
name:Junji Furuse
affiliation:
name:Kyorin University
address:
name:Department of Internal Medicine, Medical Oncology, School of Medicine, Kyorin University, Tokyo, Japan
type:PostalAddress
type:Organization
type:Person
name:Takuji Okusaka
affiliation:
name:National Cancer Center Hospital
address:
name:Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan
type:PostalAddress
type:Organization
type:Person
name:Masumi Kadoya
affiliation:
name:Shinshu University School of Medicine
address:
name:Department of Radiology, Shinshu University School of Medicine, Nagano, Japan
type:PostalAddress
type:Organization
type:Person
name:Satoshi Yamashita
affiliation:
name:Medical Affairs Oncology and Hematology, Bayer Yakuhin, Ltd.
address:
name:Medical Affairs Oncology and Hematology, Bayer Yakuhin, Ltd., Osaka, Japan
type:PostalAddress
type:Organization
type:Person
name:Yuichiro Ito
affiliation:
name:Medical Affairs Oncology and Hematology, Bayer Yakuhin, Ltd.
address:
name:Medical Affairs Oncology and Hematology, Bayer Yakuhin, Ltd., Osaka, Japan
type:PostalAddress
type:Organization
type:Person
name:Norihiro Kokudo
affiliation:
name:Graduate School of Medicine, University of Tokyo
address:
name:Hepato-Biliary-Pancreatic Surgery Division, Department of Surgery, Graduate School of Medicine, University of Tokyo, Tokyo, Japan
type:PostalAddress
type:Organization
type:Person
isAccessibleForFree:1
type:ScholarlyArticle
context:https://schema.org
ScholarlyArticle:
headline:Safety and efficacy of sorafenib in Japanese patients with hepatocellular carcinoma in clinical practice: a subgroup analysis of GIDEON
description:GIDEON was a prospective, global, non-interventional study evaluating the safety of sorafenib in patients with unresectable hepatocellular carcinoma in real-world practice. The aim of this subgroup analysis was to assess the safety and efficacy of sorafenib as used by Japanese patients. In Japan, 508 patients were valid for safety analysis. Efficacy and safety were evaluated by the Child-Pugh score. The number of patients with Child-Pugh A and B was 432 (85.0 %) and 58 (11.4 %), respectively. The median overall survival time and time to progression in patients with Child-Pugh A and Child-Pugh B were 17.4 and 4.9 months, 3.7 and 2.3 months, respectively. The most common drug-related adverse events (AEs) included hand-foot skin reaction (47.8 %), diarrhea (35.8 %) and hypertension (24.2 %). The incidences of all or drug-related AEs were similar between patients with Child-Pugh A and B. However, all or drug-related serious AEs, AEs resulting in permanent discontinuation of sorafenib and deaths were observed more frequently in patients with Child-Pugh B compared with Child-Pugh A. Duration of treatment tended to be shorter as the Child-Pugh score worsened. Sorafenib was well tolerated by Japanese HCC patients in clinical settings. Patients with Child-Pugh B had shorter duration of treatment and higher incidence of SAEs. It is important to carefully evaluate patients’ conditions and assess the benefit and risk before making a decision to treat patients with sorafenib.
datePublished:2016-04-22T00:00:00Z
dateModified:2016-04-22T00:00:00Z
pageStart:1150
pageEnd:1160
license:http://creativecommons.org/licenses/by/4.0/
sameAs:https://doi.org/10.1007/s00535-016-1204-2
keywords:
Hepatocellular carcinoma
Sorafenib
Japanese
GIDEON
Gastroenterology
Hepatology
Abdominal Surgery
Colorectal Surgery
Surgical Oncology
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00535-016-1204-2/MediaObjects/535_2016_1204_Fig1_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00535-016-1204-2/MediaObjects/535_2016_1204_Fig2_HTML.gif
isPartOf:
name:Journal of Gastroenterology
issn:
1435-5922
0944-1174
volumeNumber:51
type:
Periodical
PublicationVolume
publisher:
name:Springer Japan
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Masatoshi Kudo
affiliation:
name:Kinki University School of Medicine
address:
name:Department of Gastroenterology and Hepatology, Kinki University School of Medicine, Osaka-Sayama, Japan
type:PostalAddress
type:Organization
email:[email protected]
type:Person
name:Masafumi Ikeda
affiliation:
name:National Cancer Center Hospital East
address:
name:Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, Chiba, Japan
type:PostalAddress
type:Organization
type:Person
name:Tadatoshi Takayama
affiliation:
name:Nihon University School of Medicine
address:
name:Department of Digestive Surgery, Nihon University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
type:Person
name:Kazushi Numata
affiliation:
name:Yokohama City University Medical Center
address:
name:Gastroenterological Center, Yokohama City University Medical Center, Kanagawa, Japan
type:PostalAddress
type:Organization
type:Person
name:Namiki Izumi
affiliation:
name:Musashino Red Cross Hospital
address:
name:Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Tokyo, Japan
type:PostalAddress
type:Organization
type:Person
name:Junji Furuse
affiliation:
name:Kyorin University
address:
name:Department of Internal Medicine, Medical Oncology, School of Medicine, Kyorin University, Tokyo, Japan
type:PostalAddress
type:Organization
type:Person
name:Takuji Okusaka
affiliation:
name:National Cancer Center Hospital
address:
name:Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan
type:PostalAddress
type:Organization
type:Person
name:Masumi Kadoya
affiliation:
name:Shinshu University School of Medicine
address:
name:Department of Radiology, Shinshu University School of Medicine, Nagano, Japan
type:PostalAddress
type:Organization
type:Person
name:Satoshi Yamashita
affiliation:
name:Medical Affairs Oncology and Hematology, Bayer Yakuhin, Ltd.
address:
name:Medical Affairs Oncology and Hematology, Bayer Yakuhin, Ltd., Osaka, Japan
type:PostalAddress
type:Organization
type:Person
name:Yuichiro Ito
affiliation:
name:Medical Affairs Oncology and Hematology, Bayer Yakuhin, Ltd.
address:
name:Medical Affairs Oncology and Hematology, Bayer Yakuhin, Ltd., Osaka, Japan
type:PostalAddress
type:Organization
type:Person
name:Norihiro Kokudo
affiliation:
name:Graduate School of Medicine, University of Tokyo
address:
name:Hepato-Biliary-Pancreatic Surgery Division, Department of Surgery, Graduate School of Medicine, University of Tokyo, Tokyo, Japan
type:PostalAddress
type:Organization
type:Person
isAccessibleForFree:1
["Periodical","PublicationVolume"]:
name:Journal of Gastroenterology
issn:
1435-5922
0944-1174
volumeNumber:51
Organization:
name:Springer Japan
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
name:Kinki University School of Medicine
address:
name:Department of Gastroenterology and Hepatology, Kinki University School of Medicine, Osaka-Sayama, Japan
type:PostalAddress
name:National Cancer Center Hospital East
address:
name:Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, Chiba, Japan
type:PostalAddress
name:Nihon University School of Medicine
address:
name:Department of Digestive Surgery, Nihon University School of Medicine, Tokyo, Japan
type:PostalAddress
name:Yokohama City University Medical Center
address:
name:Gastroenterological Center, Yokohama City University Medical Center, Kanagawa, Japan
type:PostalAddress
name:Musashino Red Cross Hospital
address:
name:Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Tokyo, Japan
type:PostalAddress
name:Kyorin University
address:
name:Department of Internal Medicine, Medical Oncology, School of Medicine, Kyorin University, Tokyo, Japan
type:PostalAddress
name:National Cancer Center Hospital
address:
name:Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan
type:PostalAddress
name:Shinshu University School of Medicine
address:
name:Department of Radiology, Shinshu University School of Medicine, Nagano, Japan
type:PostalAddress
name:Medical Affairs Oncology and Hematology, Bayer Yakuhin, Ltd.
address:
name:Medical Affairs Oncology and Hematology, Bayer Yakuhin, Ltd., Osaka, Japan
type:PostalAddress
name:Medical Affairs Oncology and Hematology, Bayer Yakuhin, Ltd.
address:
name:Medical Affairs Oncology and Hematology, Bayer Yakuhin, Ltd., Osaka, Japan
type:PostalAddress
name:Graduate School of Medicine, University of Tokyo
address:
name:Hepato-Biliary-Pancreatic Surgery Division, Department of Surgery, Graduate School of Medicine, University of Tokyo, Tokyo, Japan
type:PostalAddress
ImageObject:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
name:Masatoshi Kudo
affiliation:
name:Kinki University School of Medicine
address:
name:Department of Gastroenterology and Hepatology, Kinki University School of Medicine, Osaka-Sayama, Japan
type:PostalAddress
type:Organization
email:[email protected]
name:Masafumi Ikeda
affiliation:
name:National Cancer Center Hospital East
address:
name:Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, Chiba, Japan
type:PostalAddress
type:Organization
name:Tadatoshi Takayama
affiliation:
name:Nihon University School of Medicine
address:
name:Department of Digestive Surgery, Nihon University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
name:Kazushi Numata
affiliation:
name:Yokohama City University Medical Center
address:
name:Gastroenterological Center, Yokohama City University Medical Center, Kanagawa, Japan
type:PostalAddress
type:Organization
name:Namiki Izumi
affiliation:
name:Musashino Red Cross Hospital
address:
name:Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Tokyo, Japan
type:PostalAddress
type:Organization
name:Junji Furuse
affiliation:
name:Kyorin University
address:
name:Department of Internal Medicine, Medical Oncology, School of Medicine, Kyorin University, Tokyo, Japan
type:PostalAddress
type:Organization
name:Takuji Okusaka
affiliation:
name:National Cancer Center Hospital
address:
name:Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan
type:PostalAddress
type:Organization
name:Masumi Kadoya
affiliation:
name:Shinshu University School of Medicine
address:
name:Department of Radiology, Shinshu University School of Medicine, Nagano, Japan
type:PostalAddress
type:Organization
name:Satoshi Yamashita
affiliation:
name:Medical Affairs Oncology and Hematology, Bayer Yakuhin, Ltd.
address:
name:Medical Affairs Oncology and Hematology, Bayer Yakuhin, Ltd., Osaka, Japan
type:PostalAddress
type:Organization
name:Yuichiro Ito
affiliation:
name:Medical Affairs Oncology and Hematology, Bayer Yakuhin, Ltd.
address:
name:Medical Affairs Oncology and Hematology, Bayer Yakuhin, Ltd., Osaka, Japan
type:PostalAddress
type:Organization
name:Norihiro Kokudo
affiliation:
name:Graduate School of Medicine, University of Tokyo
address:
name:Hepato-Biliary-Pancreatic Surgery Division, Department of Surgery, Graduate School of Medicine, University of Tokyo, Tokyo, Japan
type:PostalAddress
type:Organization
PostalAddress:
name:Department of Gastroenterology and Hepatology, Kinki University School of Medicine, Osaka-Sayama, Japan
name:Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, Chiba, Japan
name:Department of Digestive Surgery, Nihon University School of Medicine, Tokyo, Japan
name:Gastroenterological Center, Yokohama City University Medical Center, Kanagawa, Japan
name:Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Tokyo, Japan
name:Department of Internal Medicine, Medical Oncology, School of Medicine, Kyorin University, Tokyo, Japan
name:Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan
name:Department of Radiology, Shinshu University School of Medicine, Nagano, Japan
name:Medical Affairs Oncology and Hematology, Bayer Yakuhin, Ltd., Osaka, Japan
name:Medical Affairs Oncology and Hematology, Bayer Yakuhin, Ltd., Osaka, Japan
name:Hepato-Biliary-Pancreatic Surgery Division, Department of Surgery, Graduate School of Medicine, University of Tokyo, Tokyo, Japan
External Links {🔗}(138)
- Learn about the earnings of https://www.springernature.com/gp/authors
- What are the total earnings of https://link.springernature.com/home/?
- Explore the financials of https://order.springer.com/public/cart
- Check the income stats for https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research
- How much does https://www.editorialmanager.com/joga pull in monthly?
- How much does https://beta.springernature.com/pre-submission?journalId=535 rake in every month?
- How much does https://doi.org/10.1053%2Fj.gastro.2011.12.061 make?
- Learn about the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22537432
- How much revenue does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3338949 produce monthly?
- What's the income generated by http://scholar.google.com/scholar_lookup?&title=Epidemiology%20of%20viral%20hepatitis%20and%20hepatocellular%20carcinoma&journal=Gastroenterology&doi=10.1053%2Fj.gastro.2011.12.061&volume=142&pages=1264-1273&publication_year=2012&author=El-Serag%2CHB each month?
- Discover the revenue of https://doi.org/10.3322%2Fcaac.20107
- What are the total earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21296855?
- How much does http://scholar.google.com/scholar_lookup?&title=Global%20cancer%20statistics&journal=CA%20Cancer%20J%20Clin&doi=10.3322%2Fcaac.20107&volume=61&pages=69-90&publication_year=2011&author=Jemal%2CA&author=Bray%2CF&author=Center%2CMM earn?
- What's the total monthly financial gain of https://doi.org/10.1016%2Fj.cgh.2005.12.007?
- How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16527702 bring in?
- What's the income of http://scholar.google.com/scholar_lookup?&title=The%20association%20between%20diabetes%20and%20hepatocellular%20carcinoma%3A%20a%20systematic%20review%20of%20epidemiologic%20evidence&journal=Clin%20Gastroenterol%20Hepatol&doi=10.1016%2Fj.cgh.2005.12.007&volume=4&pages=369-380&publication_year=2006&author=El-Serag%2CHB&author=Hampel%2CH&author=Javadi%2CF?
- What are the total earnings of https://doi.org/10.7314%2FAPJCP.2012.13.3.743?
- Check the income stats for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22631642
- Learn about the earnings of http://scholar.google.com/scholar_lookup?&title=Risk%20factors%20of%20hepatocellular%20carcinoma%E2%80%93current%20status%20and%20perspectives&journal=Asian%20Pac%20J%20Cancer%20Prev&doi=10.7314%2FAPJCP.2012.13.3.743&volume=13&pages=743-752&publication_year=2012&author=Gao%2CJ&author=Xie%2CL&author=Yang%2CWS
- Learn how profitable https://doi.org/10.1016%2Fj.bpg.2006.07.002 is on a monthly basis
- What's the monthly money flow for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17223503?
- Check the income stats for http://scholar.google.com/scholar_lookup?&title=Hepatocellular%20carcinoma%20development%20in%20cirrhosis&journal=Best%20Pract%20Res%20Clin%20Gastroenterol&doi=10.1016%2Fj.bpg.2006.07.002&volume=21&pages=161-173&publication_year=2007&author=Okuda%2CH
- What's https://doi.org/10.1200%2FJCO.2005.03.196's gross income?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15860847 generate monthly?
- What's the financial gain of http://scholar.google.com/scholar_lookup?&title=Hepatocellular%20carcinoma%3A%20the%20need%20for%20progress&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2005.03.196&volume=23&pages=2892-2899&publication_year=2005&author=Thomas%2CMB&author=Zhu%2CAX?
- What's the financial outcome of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15042359?
- How much profit is http://scholar.google.com/scholar_lookup?&title=Randomized%20controlled%20trial%20of%20screening%20for%20hepatocellular%20carcinoma&journal=J%20Cancer%20Res%20Clin%20Oncol&volume=130&pages=417-422&publication_year=2004&author=Zhang%2CBH&author=Yang%2CBH&author=Tang%2CZY making per month?
- What is the monthly revenue of https://doi.org/10.1016%2FS0140-6736%2803%2914964-1?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=14667750 gross monthly?
- Check the income stats for http://scholar.google.com/scholar_lookup?&title=Hepatocellular%20carcinoma&journal=Lancet&doi=10.1016%2FS0140-6736%2803%2914964-1&volume=362&pages=1907-1917&publication_year=2003&author=Llovet%2CJM&author=Burroughs%2CA&author=Bruix%2CJ
- Check the income stats for https://doi.org/10.1111%2Fj.1365-2036.2006.02932.x
- What's the income generated by http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16696801 each month?
- What's the total monthly financial gain of http://scholar.google.com/scholar_lookup?&title=Systematic%20review%3A%20evidence-based%20management%20of%20hepatocellular%20carcinoma-an%20updated%20analysis%20of%20randomized%20controlled%20trials&journal=Aliment%20Pharmacol%20Ther&doi=10.1111%2Fj.1365-2036.2006.02932.x&volume=23&pages=1535-1547&publication_year=2006&author=Lopez%2CPM&author=Villanueva%2CA&author=Llovet%2CJM?
- What are the earnings of https://doi.org/10.1038%2Fnrc1934?
- How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16929323 make?
- http://scholar.google.com/scholar_lookup?&title=Hepatocellular%20carcinoma%20pathogenesis%3A%20from%20genes%20to%20environment&journal=Nat%20Rev%20Cancer&doi=10.1038%2Fnrc1934&volume=6&pages=674-687&publication_year=2006&author=Farazi%2CPA&author=DePinho%2CRA's financial summary
- How much does https://doi.org/10.1097%2FMOG.0b013e32832962a1 pull in?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19387255 rake in every month?
- What's the income of http://scholar.google.com/scholar_lookup?&title=Pathogenesis%20of%20hepatocellular%20carcinoma%20and%20molecular%20therapies&journal=Curr%20Opin%20Gastroenterol&doi=10.1097%2FMOG.0b013e32832962a1&volume=25&pages=186-194&publication_year=2009&author=Minguez%2CB&author=Tovar%2CV&author=Chiang%2CD?
- What's the financial gain of https://doi.org/10.1158%2F0008-5472.CAN-04-1443?
- Monthly income for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15466206
- Get to know http://scholar.google.com/scholar_lookup?&title=BAY%2043-9006%20exhibits%20broad%20spectrum%20oral%20antitumor%20activity%20and%20targets%20the%20RAF%2FMEK%2FERK%20pathway%20and%20receptor%20tyrosine%20kinases%20involved%20in%20tumor%20progression%20and%20angiogenesis&journal=Cancer%20Res&doi=10.1158%2F0008-5472.CAN-04-1443&volume=64&pages=7099-7109&publication_year=2004&author=Wilhelm%2CSM&author=Carter%2CC&author=Tang%2CL's earnings
- What's https://doi.org/10.1002%2Fhep.24199's gross income?
- What's the revenue for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21374666?
- Profit of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3084991
- Earnings of http://scholar.google.com/scholar_lookup?&title=Management%20of%20hepatocellular%20carcinoma%3A%20an%20update&journal=Hepatology&doi=10.1002%2Fhep.24199&volume=53&pages=1020-1022&publication_year=2011&author=Bruix%2CJ&author=Sherman%2CM
- How much income is https://doi.org/10.1016%2FS1470-2045%2808%2970285-7 earning monthly?
- Learn how profitable http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19095497 is on a monthly basis
- How much does http://scholar.google.com/scholar_lookup?&title=Efficacy%20and%20safety%20of%20sorafenib%20in%20patients%20in%20the%20Asia-Pacific%20region%20with%20advanced%20hepatocellular%20carcinoma%3A%20a%20phase%20III%20randomised%2C%20double-blind%2C%20placebo-controlled%20trial&journal=Lancet%20Oncol&doi=10.1016%2FS1470-2045%2808%2970285-7&volume=10&pages=25-34&publication_year=2009&author=Cheng%2CAL&author=Kang%2CYK&author=Chen%2CZ gross monthly?
- How much does https://doi.org/10.1056%2FNEJMoa0708857 pull in monthly?
- Find out how much http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18650514 earns monthly
- How much does http://scholar.google.com/scholar_lookup?&title=Sorafenib%20in%20advanced%20hepatocellular%20carcinoma&journal=N%20Engl%20J%20Med&doi=10.1056%2FNEJMoa0708857&volume=359&pages=378-390&publication_year=2008&author=Llovet%2CJM&author=Ricci%2CS&author=Mazzaferro%2CV net monthly?
- What's the financial intake of https://doi.org/10.1111%2Fj.1742-1241.2010.02414.x?
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20642705 income
- Earnings of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2905618
- What are the earnings of http://scholar.google.com/scholar_lookup?&title=Design%20and%20rationale%20for%20the%20non-interventional%20global%20investigation%20of%20therapeutic%20decisions%20in%20hepatocellular%20carcinoma%20and%20of%20its%20treatment%20with%20sorafenib%20%28GIDEON%29%20study&journal=Int%20J%20Clin%20Pract&doi=10.1111%2Fj.1742-1241.2010.02414.x&volume=64&pages=1034-1041&publication_year=2010&author=Lencioni%2CR&author=Marrero%2CJ&author=Venook%2CA?
- https://doi.org/10.1111%2Fijcp.12352's financial summary
- How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24283303 make?
- What are the earnings of http://scholar.google.com/scholar_lookup?&title=GIDEON%20%28global%20investigation%20of%20therapeutic%20decisions%20in%20hepatocellular%20carcinoma%20and%20of%20its%20treatment%20with%20sorafenib%29%3A%20second%20interim%20analysis&journal=Int%20J%20Clin%20Pract&doi=10.1111%2Fijcp.12352&volume=68&pages=609-617&publication_year=2014&author=Lencioni%2CR&author=Kudo%2CM&author=Ye%2CSL?
- Learn about the earnings of https://doi.org/10.1111%2Fj.1742-1241.2012.02940.x
- Monthly income for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22698419
- How much money does http://scholar.google.com/scholar_lookup?&title=First%20interim%20analysis%20of%20the%20GIDEON%20%28global%20investigation%20of%20therapeutic%20decisions%20in%20hepatocellular%20carcinoma%20and%20of%20its%20treatment%20with%20sorafenib%29%20non-interventional%20study&journal=Int%20J%20Clin%20Pract&doi=10.1111%2Fj.1742-1241.2012.02940.x&volume=66&pages=675-683&publication_year=2012&author=Lencioni%2CR&author=Kudo%2CM&author=Ye%2CSL generate?
- What are the total earnings of http://scholar.google.com/scholar_lookup?&title=Nexavar%C2%AE%20Tablets%20200%C2%A0Mg%20%28nonproprietary%20nane%3A%20sorafenib%20tosylate%20tablets%29%20specific%20drug%20use%20investigation%20interim%20report%20%28unresectable%20hepatocellular%20carcinoma%29&publication_year=2012?
- What's the profit of https://doi.org/10.2214%2Fajr.175.3.1750699?
- How much cash flow does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10954453 have monthly?
- Find out how much http://scholar.google.com/scholar_lookup?&title=Comparison%20of%20CT%20findings%20with%20resected%20specimens%20after%20chemoembolization%20with%20iodized%20oil%20for%20hepatocellular%20carcinoma&journal=AJR%20Am%20J%20Roentgenol&doi=10.2214%2Fajr.175.3.1750699&volume=175&pages=699-704&publication_year=2000&author=Takayasu%2CK&author=Arii%2CS&author=Matsuo%2CN earns monthly
- https://doi.org/10.1111%2Fj.1872-034X.2010.00674.x's revenue stream
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20633194 gross monthly?
- How much does http://scholar.google.com/scholar_lookup?&title=Response%20evaluation%20criteria%20in%20cancer%20of%20the%20liver%20%28RECICL%29%20proposed%20by%20the%20Liver%20Cancer%20Study%20Group%20of%20Japan%20%282009%20revised%20version%29&journal=Hepatol%20Res&doi=10.1111%2Fj.1872-034X.2010.00674.x&volume=40&pages=686-692&publication_year=2010&author=Kudo%2CM&author=Kubo%2CS&author=Takayasu%2CK generate monthly?
- How much income is https://doi.org/10.1055%2Fs-0030-1247132 earning monthly?
- How much money does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20175033 make?
- Revenue of http://scholar.google.com/scholar_lookup?&title=Modified%20RECIST%20%28mRECIST%29%20assessment%20for%20hepatocellular%20carcinoma&journal=Semin%20Liver%20Dis&doi=10.1055%2Fs-0030-1247132&volume=30&pages=52-60&publication_year=2010&author=Lencioni%2CR&author=Llovet%2CJM
- What's https://doi.org/10.1016%2FS0168-8278%2815%2930585-7's gross income?
- How much does http://scholar.google.com/scholar_lookup?&title=GIDEON%3A%20a%20retrospective%20analysis%20of%20prognostic%20factors%5BAbstract%5D&journal=J%20Hepatol&doi=10.1016%2FS0168-8278%2815%2930585-7&volume=62&issue=suppl%202&publication_year=2015&author=Bronowicki%2CJP&author=Kudo%2CM&author=Lencioni%2CR net monthly?
- Explore the financials of https://doi.org/10.1016%2FS0168-8278%2814%2960112-4
- How much income is http://scholar.google.com/scholar_lookup?&title=An%20international%20collaborative%20study%20assessing%20the%20role%20of%20aetiology%20and%20stage%20in%20survival%20in%20HCC-implications%20for%20screening&journal=J%20Hepatol&doi=10.1016%2FS0168-8278%2814%2960112-4&volume=60&issue=suppl&pages=S45-S46&publication_year=2014&author=Johnson%2CP&author=Berhane%2CS&author=Satomura%2CS earning monthly?
- What's the total monthly financial gain of https://doi.org/10.1159%2F000342749?
- How much income does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24159578 have?
- How much does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3760465 gross monthly?
- How much income does http://scholar.google.com/scholar_lookup?&title=Japan%E2%80%99s%20successful%20model%20of%20nationwide%20hepatocellular%20carcinoma%20surveillance%20highlighting%20the%20urgent%20need%20for%20global%20surveillance&journal=Liver%20Cancer&doi=10.1159%2F000342749&volume=1&pages=141-143&publication_year=2012&author=Kudo%2CM have?
- How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=25213161 produce monthly?
- Get to know what's the income of http://scholar.google.com/scholar_lookup?&title=Randomized%20phase%20III%20trial%20of%20regorafenib%20in%20metastatic%20colorectal%20cancer%3A%20analysis%20of%20the%20CORRECT%20Japanese%20and%20non-Japanese%20subpopulations&journal=Invest%20New%20Drugs&doi=10.1007%2Fs10637-014-0154-x&volume=33&pages=740-750&publication_year=2015&author=Yoshino%2CT&author=Komatsu%2CY&author=Yamada%2CY
- https://doi.org/10.1159%2F000327577's revenue stream
- See how much http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21829027 makes per month
- How much does http://scholar.google.com/scholar_lookup?&title=Management%20of%20hepatocellular%20carcinoma%20in%20Japan%3A%20consensus-based%20clinical%20practice%20guidelines%20proposed%20by%20the%20Japan%20Society%20of%20Hepatology%20%28JSH%29%202010%20updated%20version&journal=Dig%20Dis&doi=10.1159%2F000327577&volume=29&pages=339-364&publication_year=2011&author=Kudo%2CM&author=Izumi%2CN&author=Kokudo%2CN pull in monthly?
- Get to know what's the income of https://doi.org/10.1159%2F000368142
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=25427730's financial summary
- What's the financial outcome of http://scholar.google.com/scholar_lookup?&title=Transarterial%20chemoembolization%20failure%2Frefractoriness%3A%20JSH-LCSGJ%20criteria%202014%20update&journal=Oncology&doi=10.1159%2F000368142&volume=87&issue=Suppl%201&pages=22-31&publication_year=2014&author=Kudo%2CM&author=Matsui%2CO&author=Izumi%2CN?
- What's the financial gain of https://doi.org/10.1159%2F000365993?
- How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=25227534 produce monthly?
- How much does http://scholar.google.com/scholar_lookup?&title=Efficacy%20of%20sorafenib%20in%20intermediate-stage%20hepatocellular%20carcinoma%20patients%20refractory%20to%20transarterial%20chemoembolization&journal=Oncology&doi=10.1159%2F000365993&volume=87&pages=330-341&publication_year=2014&author=Ogasawara%2CS&author=Chiba%2CT&author=Ooka%2CY bring in each month?
- How much does https://doi.org/10.1159%2F000367743 earn?
- How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=26734579 generate?
- How much revenue does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4698649 bring in?
- What's the income generated by http://scholar.google.com/scholar_lookup?&title=Effectiveness%20of%20sorafenib%20in%20patients%20with%20transcatheter%20arterial%20chemoembolization%20%28TACE%29%20refractory%20and%20intermediate-stage%20hepatocellular%20carcinoma&journal=Liver%20Cancer&doi=10.1159%2F000367743&volume=4&pages=253-262&publication_year=2015&author=Arizumi%2CT&author=Ueshima%2CK&author=Minami%2CT each month?
- How much profit does https://citation-needed.springer.com/v2/references/10.1007/s00535-016-1204-2?format=refman&flavour=references generate?
- Check the income stats for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Masatoshi%20Kudo
- https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Masatoshi%20Kudo%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's revenue stream
- How much profit is https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Masafumi%20Ikeda making per month?
- How much profit does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Masafumi%20Ikeda%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en make?
- What's the financial gain of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Tadatoshi%20Takayama?
- Earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Tadatoshi%20Takayama%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Kazushi%20Numata make?
- Revenue of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Kazushi%20Numata%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- Financial intake of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Namiki%20Izumi
- Income figures for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Namiki%20Izumi%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- How profitable is https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Junji%20Furuse?
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Junji%20Furuse%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en earn?
- What's the monthly money flow for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Takuji%20Okusaka?
- How much profit does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Takuji%20Okusaka%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en make?
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Masumi%20Kadoya rake in every month?
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Masumi%20Kadoya%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en earn?
- What is the monthly revenue of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Satoshi%20Yamashita?
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Satoshi%20Yamashita%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en net monthly?
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Yuichiro%20Ito earn?
- Find out how much https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Yuichiro%20Ito%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en earns monthly
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Norihiro%20Kokudo net monthly?
- Income figures for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Norihiro%20Kokudo%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- How much profit is https://static-content.springer.com/esm/art%3A10.1007%2Fs00535-016-1204-2/MediaObjects/535_2016_1204_MOESM1_ESM.docx making per month?
- What's the total monthly financial gain of http://creativecommons.org/licenses/by/4.0/?
- How much does https://s100.copyright.com/AppDispatchServlet?title=Safety%20and%20efficacy%20of%20sorafenib%20in%20Japanese%20patients%20with%20hepatocellular%20carcinoma%20in%20clinical%20practice%3A%20a%20subgroup%20analysis%20of%20GIDEON&author=Masatoshi%20Kudo%20et%20al&contentID=10.1007%2Fs00535-016-1204-2©right=The%20Author%28s%29&publication=0944-1174&publicationDate=2016-04-22&publisherName=SpringerNature&orderBeanReset=true&oa=CC%20BY make?
- How much revenue does https://crossmark.crossref.org/dialog/?doi=10.1007/s00535-016-1204-2 generate?
- What are the total earnings of https://citation-needed.springer.com/v2/references/10.1007/s00535-016-1204-2?format=refman&flavour=citation?
- How profitable is https://authorservices.springernature.com/go/sn/?utm_source=SNLinkfooter&utm_medium=Web&utm_campaign=SNReferral?
- Learn how profitable https://www.springernature.com/gp/products is on a monthly basis
- How much does https://www.springernature.com/gp/librarians make?
- How much revenue does https://www.springernature.com/gp/societies produce monthly?
- Profit of https://www.springernature.com/gp/partners
- What's the profit of https://www.springer.com/?
- Learn about the earnings of https://www.nature.com/
- Discover the revenue of https://www.biomedcentral.com/
- How much does https://www.palgrave.com/ make?
- How much revenue does https://www.apress.com/ bring in?
- How much does https://www.springernature.com/gp/legal/ccpa make?
- How much does https://www.springernature.com/gp/info/accessibility make?
- Earnings of https://support.springernature.com/en/support/home
- What's the income generated by https://support.springernature.com/en/support/solutions/articles/6000255911-subscription-cancellations each month?
- What's the income generated by https://www.springernature.com/ each month?
Analytics and Tracking {📊}
- Google Tag Manager
Libraries {📚}
- Clipboard.js
- Prism.js
CDN Services {📦}
- Crossref